2/8/2018CFDA Releases Third Announcement for Excessively-Supplied Drug Product...

2/8/2018CDE Release Essential Dossier Data Requirements for PD-1/PD-L1 mAb Dru...

2/8/2018Chinese Researchers Finds New Potential Asthma Treatment

2/8/2018Roivant Sciences and ArQule Enter into License Agreement for Derazanti...

2/7/2018Review of Chinese Pharma Deals, R&D and Regulatory Developments in...

2/6/2018TaiGen's New IV Antibiotic Nemonoxacin Gets Fast Track Designation in ...

2/6/2018Xbrane Biopharma Licenses GnRH Analog Spherotide to CR Pharma in China

2/6/2018CFDA Vice Minister SUN Xianze to Leave the Agency

2/6/2018Pfizer, DL Medicine Enter Drug Discovery Partnership

2/6/2018BeiGene Announces Commercial Availability of VIDAZA (Azacitidine for I...

2/6/2018China to Step Up Surveillance of Online Drug Sales

2/6/2018South Korea's Pharmaceutical Export to China Jumped Nearly 400% in 201...

2/5/2018Shanghai AIC Penalizes U.S.-China Joint Venture for Providing Overseas...

2/5/2018Heads of CFDA and the Bitish Medicines and Healthcare Products Regulat...

2/5/2018More Provincial Governments Liberalize Non-essential Drug Use in Prima...

2/2/2018Shanghai AIC Terminates Antimonopoly Investigation of the City's GPO S...

2/2/2018Fosun-backed Shanghai Henlius Biotech Plans IPO in Hong Kong

2/2/2018AstraZeneca Counts on China and Anticancer Sales for Renewed Growth

2/2/2018This Is Why Chinese Companies Are Suddenly Targeting Australian Health...

2/2/2018Puma Biotech and CANbridge Enter Exclusive Licensing for NERLYNX (nera...

2/2/2018Roche CEO Considers China Business "A Large Focus"

2/2/2018Shanghai Pharma Completes Acquisition of Cardinal Health's China Busin...

2/2/2018Recent Executive Moves

2/2/2018Four Central Government Agencies Issue Joint Notice for Centralized Pr...

2/1/2018Lundbeck Launches PD Drug Azilect in China

1/31/2018BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizu...

1/31/2018CJ Healthcare Licenses EPO Biosimilar to NCPC GeneTech

1/31/2018Financial-related Company News in Brief

1/31/2018Light at the End of Tunnel in the Supposedly Hopeful Year of the "...

1/31/2018Novartis Launches Asthma Drug Xolair (omalizumab) in China

Page:358/799 Total number of articles:23944: [First][<<] [356] [357] [358] [359] [360] [>>] [End]